Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 30

Results For "tablets"

431 News Found

Shilpa Medicare updates on Europe GMP inspection at Unit 4, Jadcherla, Telangana
Drug Approval | January 28, 2024

Shilpa Medicare updates on Europe GMP inspection at Unit 4, Jadcherla, Telangana

The company intends to respond to the two minor observations within the stipulated time


Alembic Pharmaceuticals received 8 USFDA approvals in Q3FY24
Drug Approval | January 03, 2024

Alembic Pharmaceuticals received 8 USFDA approvals in Q3FY24

The company has received five final approvals


Venus Remedies' R3SET forays into wellness
News | December 20, 2023

Venus Remedies' R3SET forays into wellness

The launch of R3SET Detox Candies positions the brand at the forefront of the wellness journey


AstraZeneca Pharma India receives permission to Import formulations of new drug for sale
News | November 23, 2023

AstraZeneca Pharma India receives permission to Import formulations of new drug for sale

The receipt of this permission paves way for the launch of Olaparib film coated tablets in India


Lubrizol launches carbopol polymers for nutraceuticals with new EU good grade approval
News | October 31, 2023

Lubrizol launches carbopol polymers for nutraceuticals with new EU good grade approval

The European Commission approved the use of Carbopol as an additive for liquid and solid food supplements in the EU


Lupin enters into BTA with Lupin Manufacturing Solutions
News | October 17, 2023

Lupin enters into BTA with Lupin Manufacturing Solutions

Lupin enters into BTA with Lupin Manufacturing Solutions


Alembic received 6 USFDA approvals during Q2FY24
Drug Approval | October 05, 2023

Alembic received 6 USFDA approvals during Q2FY24

The company has received six final approvals that includes Chlorpromazine Hydrochloride Tablets


Hermes Pharma to invest €25 million to bolster manufacturing capabilities
News | September 27, 2023

Hermes Pharma to invest €25 million to bolster manufacturing capabilities

The investment will help the company meet soaring demand for user-friendly oral dosage form development and manufacturing


Strides receives USFDA approval for Sevelamer Carbonate for oral suspension
Drug Approval | September 11, 2023

Strides receives USFDA approval for Sevelamer Carbonate for oral suspension

The products will be manufactured at the company's facility in Bengaluru


Shilpa Medicare receives UK MHRA approval for mouth-dissolving strips to treat illnesses
News | September 03, 2023

Shilpa Medicare receives UK MHRA approval for mouth-dissolving strips to treat illnesses

This approval has come from the company's finished dosage form manufacturing facility